The treatment of gastroesophageal reflux disease requires an individua
lized approach, and aims to remove the symptoms, to heal the esophagit
is, and to prevent the recurrence or complications. These objectives a
re obtained reducing the incidence of the damaging reflux: into the es
ophagus by improving the antireflux barrier, decreasing the gastric ac
id component, enhancing the esophageal clearance. Depending on the sev
erity of the disease, gastroesophageal reflux disease may be managed t
hrough a combination of lifestyle modifications, antacid-anti-refluxan
t drugs, prokinetic drugs, receptor-H2- antagonists, proton pump inhib
itors or surgery. Antireflux surgery should be considered in several s
ituations. All patients, especially at a young age, who have an insuff
icient response to medical management, presenting with a mechanically
defective lower esophageal sphincter or with various grades of complic
ations are candidates for surgery. Although a surgery is rarely used a
s treatment option in patients affected by gastroesophageal reflux dis
ease, the percentage of success is upper to 80-90 %, especially after
the introduction of minimally invasive procedures, with significantly
ad vitam reduced costs.